Interleukin 6 receptor inhibition in primary Sjgren syndrome: a multicentre double-blind randomised placebo-controlled trial

Post time 2026-8-16 01:01:07

Edited by AyaMuhammed at 2026-8-16 20:29

journal：Annals of the Rheumatic Diseases

Authors：Renaud Felten; Valérie Devauchelle-Pensec; Raphaèle Seror; Pierre Duffau; David Saadoun; Eric Hachulla; Hatron Pierre Yves; Carine Salliot; Aleth Perdriger; Jacques Morel; Arsène Mékinian; Olivier Vittecoq; Jean-Marie Berthelot; Emanuelle Dernis; Veronique Le Guern; Philippe Dieudé; Claire Larroche; Christophe Richez; Thierry Martin; Charles Zarnitsky; Gilles Blaison; Pierre Kieffer; Franois Maurier; Azeddine Dellal; Stephanie Rist; Emmanuel Andres; Anne Contis; Emmanuel Chatelus; Christelle Sordet; Jean Sibilia; Cécile Arnold; Mira Y Tawk; Ouafaa Aberkane; Lise Holterbach; Patrice Cacoub; Alain Saraux; Xavier Mariette; Nicolas Meyer; Jacques-Eric Gottenberg

Published date：2021-3-

DOI：10.1136/annrheumdis-2020-218467

PDF link：https://www.sciencedirect.com/sc ... 003496724005260/pdf

Article link：https://doi.org/10.1136/annrheumdis-2020-218467

Article Source：Elsevier BV。

Remark：

[BMJ] Interleukin 6 receptor inhibition in primary Sjgren syndrome: a multicentre double-blind randomised placebo-controlled trial

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[BMJ] Interleukin 6 receptor inhibition in primary Sjgren syndrome: a multicentre double-blind randomised placebo-controlled trial Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[BMJ] Interleukin 6 receptor inhibition in primary Sjgren syndrome: a multicentre double-blind randomised placebo-controlled trial